SARS-CoV-2 pandemic and repercussions for male infertility patients: A proposal for the individualized provision of andrological services.

Autor: Esteves SC; ANDROFERT, Andrology and Human Reproduction Clinic, Campinas, Brazil.; Department of Surgery (Division of Urology), University of Campinas (UNICAMP), Campinas, Brazil.; Faculty of Health, Aarhus University, Aarhus, Denmark., Lombardo F; Department of Medical Physiopathology, University of Rome 'La Sapienza', Rome, Italy., Garrido N; IVI Foundation, Health Research Institute La Fe, Valencia, Spain., Alvarez J; Centro ANDROGEN, La Coruña, Spain., Zini A; Division of Urology, Department of Surgery, St. Mary's Hospital, McGill University, Montreal, QC, Canada., Colpi GM; Andrology Service, Procrea Swiss Fertility Center, Lugano, Switzerland.; Andrology and IVF Department, San Carlo Cinic, Paderno Dugnano/Milano, Italy., Kirkman-Brown J; Centre for Human Reproductive Science, IMSR, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.; Birmingham Women's Fertility Centre, Birmingham Women's & Children's NHS Foundation Trust, Birmingham, UK., Lewis SEM; Queens University Belfast, Belfast, UK.; Examenlab Ltd., Belfast, UK., Björndahl L; ANOVA, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden., Majzoub A; Department of Urology, Hamad Medical Corporation, Doha, Qatar.; Weill Cornell Medicine-Qatar, Doha, Qatar., Cho CL; Department of Surgery, Union Hospital, Hong Kong, Hong Kong.; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong., Vendeira P; Urology/Andrology Unit, Saúde Atlântica, Clínica do Dragão, Porto, Portugal., Hallak J; Androscience, Science and Innovation Center in Andrology and High-Complex Clinical and Andrology Laboratory, São Paulo, Brazil.; Division of Urology, University of São Paulo, São Paulo, Brazil.; Men's Health Study Group, Institute for Advanced Studies, University of São Paulo, São Paulo, Brazil.; Reproductive Toxicology Unit, Department of Pathology, University of São Paulo, São Paulo, Brazil., Amar E; Cabinet D'Andrologie Victor Hugo, American Hospital of Paris Reproductive Center, Paris, France., Cocuzza M; Human Reproduction Center, Division of Urology, University of São Paulo, São Paulo, Brazil., Bento FC; ANDROFERT, Andrology and Human Reproduction Clinic, Campinas, Brazil., Figueira RC; ANDROFERT, Andrology and Human Reproduction Clinic, Campinas, Brazil., Sciorio R; Edinburgh Assisted Conception Programme, EFREC, Royal Infirmary of Edinburgh, Edinburgh, UK., Laursen RJ; Fertility Clinic Skive, Skive Regional Hospital, Skive, Denmark., Metwalley AM; IVF Laboratory, Al Saad Specialist Hospitals, Jeddah, Saudi Arabia.; Reproductive Medicine and Genetic Unit, GEBRI, Sadat City, Egypt., Jindal SK; Division of Reproductive Medicine and Andrology, Jindal Hospital, Meerut, India., Parekattil S; PUR Clinic and University of Central Florida, Clermont, FL, USA., Ramasamy R; Department of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA., Alviggi C; Department of Neuroscience, Reproductive Science and Odontostomatology, University of Naples Federico II, Naples, Italy., Humaidan P; Faculty of Health, Aarhus University, Aarhus, Denmark.; Fertility Clinic Skive, Skive Regional Hospital, Skive, Denmark., Yovich JL; PIVET Medical Centre, Perth, WA, Australia.; Curtin University, Perth, WA, Australia.; Cairns Fertility Centre, Cairns, QLD, Australia., Agarwal A; Andrology Center, Department of Urology, Cleveland Clinic, Cleveland, OH, USA.
Jazyk: angličtina
Zdroj: Andrology [Andrology] 2021 Jan; Vol. 9 (1), pp. 10-18. Date of Electronic Publication: 2020 May 22.
DOI: 10.1111/andr.12809
Abstrakt: The prolonged lockdown of health facilities providing non-urgent gamete cryopreservation-as currently recommended by many reproductive medicine entities and regulatory authorities due to the SARS-CoV-2 pandemic will be detrimental for subgroups of male infertility patients. We believe the existing recommendations should be promptly modified and propose that the same permissive approach for sperm banking granted for men with cancer is expanded to other groups of vulnerable patients. These groups include infertility patients (eg, azoospermic and cryptozoospermic) undergoing medical or surgical treatment to improve sperm quantity and quality, as well as males of reproductive age affected by inflammatory and systemic auto-immune diseases who are about to start treatment with gonadotoxic drugs or who are under remission. In both scenarios, the "fertility window" may be transitory; postponing diagnostic semen analysis and sperm banking in these men could compromise the prospects of biological parenthood. Moreover, we provide recommendations on how to continue the provision of andrological services in a considered manner and a safe environment. Our opinion is timely and relevant given the fact that fertility services are currently rated as of low priority in most countries.
(© 2020 American Society of Andrology and European Academy of Andrology.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje